MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

Zhenghai Shen; Xing Wang; Xiaotian Yu; Yun Zhang; Lei Qin

doi:10.18632/oncotarget.20060

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

Zhenghai Shen, Xing Wang, Xiaotian Yu, Yun Zhang and Lei Qin _

PDF | HTML | How to cite

Oncotarget. 2017; 8:72197-72204. https://doi.org/10.18632/oncotarget.20060

Metrics: PDF 1336 views | HTML 2265 views | ?

Abstract

Zhenghai Shen1,2, Xing Wang2, Xiaotian Yu2, Yun Zhang2 and Lei Qin1

1Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China

2Department of General Surgery, Yixing People’s Hospital, Yixing, Wuxi 214200, China

Correspondence to:

Lei Qin, email: [email protected]

Keywords: MMP16, hepatocellular carcinoma, prognosis, TCGA, epithelial-mesenchymal transition

Received: June 28, 2017 Accepted: July 26, 2017 Published: August 07, 2017

ABSTRACT

Matrix metalloproteinase (MMPs) participates in multiple biological behaviors and plays an important role in regulating tumor invasion. However, the functions of MMP16 in hepatocellular carcinoma (HCC) remains unknown. The prognostic value of MMP16 was studied in TCGA database and validation cohort. MMP16-silencing HCC cells (HepG2 and HCCLM3) were used for evaluating cell proliferation and invasion by CCK-8 and Transwell assays. Our results showed that the MMP16 was a predictor for overall survival in patients with HCC (HR: 1.169, 95% CI: 1.034–1.321, P = 0.013) in TCGA database. In validation cohort, MMP16 expression was an independent predictor for survival in both univariate and multivariate analysis (P < 0.05). Furthermore, knockdown MMP16 weakened the cell invasive potential by inhibiting epithelial-mesenchymal transition (EMT) process. Therefore, our findings showed that MMP16 was a prognostic factor in HCC, ectopic MMP16 expression promoted invasion of HCC cells by inducing EMT process, suggesting a tumor oncogenic function in HCC and provides the potential therapeutic target for the treatment of HCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20060

Publication Alerts

Research Papers:

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

Abstract